Regeneron beats Q2 earnings estimates on strong Dupixent sales, despite challenges with Eylea and regulatory delays.
Trump administration plans pilot program to cover expensive obesity drugs in Medicaid and Medicare, highlighting concerns over long-term affordability and need for lifestyle coaching.
Stevie Nicks postpones tour, announces album reissue due to fractured shoulder
Regeneron beats Q2 earnings estimates on strong Dupixent sales, despite challenges with Eylea and regulatory delays.
Trump administration plans pilot program to cover expensive obesity drugs in Medicaid and Medicare, highlighting concerns over long-term affordability and need for lifestyle coaching.
Stevie Nicks postpones tour, announces album reissue due to fractured shoulder